GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack tested for tough brain cancers
Disease control Not yet recruitingThis study is testing a combination of two drugs, retifanlimab and DFMO, for people with aggressive brain tumors that have started growing again. The first goal is to find a safe and tolerable dose of DFMO to give with retifanlimab. Researchers will then see if this combination h…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pulsed radiation offers hope for brain cancer patients to live longer, think clearer
Disease control Not yet recruitingThis study is for adults newly diagnosed with a specific, aggressive type of brain tumor called MGMT-unmethylated glioblastoma. It compares a new way of delivering radiation, called Temporally-Modulated Pulsed Radiation Therapy (TMPRT), against the current standard radiation. Bot…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC